Clinical trials demonstrate that patients who stick with their dose through the initial adjustment phase experience dramatically fewer side effects in subsequent months compared to those who discontinue early
Electrolyte Imbalance : By slowing gastric emptying, semaglutide can cause nausea and vomiting, leading to poor intake of fluids and food
The GLP-1 prescription requirements are based on clinical guidelines established by medical organizations and FDA approval criteria
In addition, in the pediatric trial (6-11 years of age), herpes viral infections occurred in 0% of Dupixent patients every four weeks, 2% of Dupixent patients every two weeks, and 5% for patients on TCS alone
phentermine (Adipex-P, Lomaira)* phendimetrazine (Bontril)* benzphetamine (Regimex, Didrex)* orlistat (Xenical, alli) phentermine and topiramate ER (Qsymia) Plenity naltrexone HCl and bupropion HCl (CONTRAVE) liraglutide injection (Saxenda) semaglutide injection (wegovy) *Approved for short term use Approved for long term (chronic) use Tirzepatide (Mounjaro) is a new medication known as a "twincreatin" because it acts on the receptors for two hunger hormones GIP and GLP-1